What motivates hospital supervisors?
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to D S Pathak.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The purpose of this study was to evaluate the implementation of the Drug Export Amendments Act of 1986 (DEAA). The study methods involved calculating the time period between the submission of an application for export of a drug to the Food and Drug Administration (FDA) and its publication in the Federal Register, and the time taken by the FDA to reach a decision on the application. These parameters were then compared with the time limits specified in the DEAA. The analysis was conducted at four levels--overall for all pharmaceuticals, by therapeutic category of pharmaceutical, by country of export, and by type of company. At all four levels, we found that the publication and decision times were greater than the time limits specified in the DEAA. This suggests the existence of a "drug export lag," which includes a "publication time lag" (18.56 days) and an "FDA decision time lag" (182.26 days). The implications of these lags for the competitiveness of the US pharmaceutical industry in the global market are discussed and suggestions are provided.
In contrast with cross-sectional designs used in previous studies, this exploratory study compared survey data from 127 matched pairs of clinical pharmacists and physicians working together. Physicians' perceptions of the importance of clinical pharmacy activities for patient care and the competence of pharmacists performing the activities were examined for their influence on prescribing behavior in an institutional setting. Data from a national survey showed that physicians rated pharmacists higher regarding recommendations based on drug use evaluations (p = 0.004) and competency to provide all clinical pharmacy services. Scores for pharmacokinetics ratings were similar between pharmacists and physicians (p = 0.168). Pharmacists rated the importance of recommendations based on cost-effectiveness higher than physicians (p = 0.012). Overall, physicians' perceptions of activity importance for patient care and pharmacist competency appear to dictate pharmacists' influence on physician prescribing behavior (R = 0.723).
We hypothesized that a pharmacist-provided comprehensive education program in conjunction with care provided by a pulmonologist would lead to improved economic, clinical, and humanistic outcomes in adults with asthma, compared with similar patients receiving care from a pulmonologist alone. The experimental group reported receiving more information about asthma self-management (p=0.001), were more likely to monitor peak flow readings (p=0.004), and had increased satisfaction with care, and perceived higher quality of care. Both groups had less lost productivity, fewer emergency department visits, fewer hospitalizations, and fewer physician visits, as well as improvement in symptoms scores within 45 days. Both groups improved in all functional status domains except the mental component score of the SF-12. Our results show a positive impact on outcomes in adults with asthma who received pharmaceutical care.